ArticleVirus genes2026
Generation of an infectious cDNA clone of BJ-Swzp-2022, a Group III Isolate of Getah Virus.
Article in Virus genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Getah virus (GETV), a mosquito-borne arbovirus, possesses many susceptible hosts, including pigs, horses, cattle, and blue foxes. Currently, the biological characteristics and pathogenic mechanisms of GETV remain to be investigated. A GETV, isolated from a contaminated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) live vaccine, was designated as BJ-Swzp-2022. Subsequently, the complete genome of the GETV BJ-Swzp-2022 was sequenced to construct a full-length infectious cDNA clone using T7 RNA polymerase. Transfection of BSR T7/5 cells expressing T7 RNA polymerase with this infectious clone resulted in the rescue of GETV, which exhibited replication and replication characteristics similar to those of the parental virus. Establishing this platform would facilitate understanding the pathogenic mechanisms of GETV and developing novel vaccines.
Indexed as
Identifiers
41653382What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.